Standard Biotools (LAB) Gross Margin (2010 - 2026)
Standard Biotools (LAB) reported Gross Margin of 53.48% for Q1 2026, down 116.0% year-over-year from 334.22% in Q1 2025, and up 11.8% on a QoQ basis from 47.83% in Q4 2025.
Standard Biotools (LAB) has 17 years of Gross Margin data on file, last reported at 53.48% in Q1 2026.
- Quarterly Gross Margin fell 116.0% year-over-year to 53.48% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 49.62% (down 51.0% YoY) and the FY2025 annual result came in at 49.86%, up 54.0% from the prior year.
- Gross Margin climbed to 53.48% in Q1 2026 per LAB's latest filing, from 47.83% in the prior quarter.
- Across five years, Gross Margin topped out at 92.73% in Q1 2022 and bottomed at 23.58% in Q2 2022.
- The 5-year median for Gross Margin is 48.51% (2025), against an average of 49.19%.
- Peak annual rise in Gross Margin reached 2559 bps in 2023, while the deepest fall reached 4383 bps in 2023.
- Tracing LAB's Gross Margin over 5 years: stood at 41.33% in 2022, then gained by 15 bps to 47.39% in 2023, then fell by 3 bps to 45.84% in 2024, then increased by 4 bps to 47.83% in 2025, then gained by 12 bps to 53.48% in 2026.
- Per Business Quant, the three latest LAB Gross Margin figures stand at 53.48% (Q1 2026), 47.83% (Q4 2025), and 48.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | 53.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.48% |
| Dec 31, 2025 | 47.83% |
| Sep 30, 2025 | 48.51% |
| Jun 30, 2025 | 48.84% |
| Mar 31, 2025 | 54.64% |
| Dec 31, 2024 | 45.84% |
| Sep 30, 2024 | 54.90% |
| Jun 30, 2024 | 46.12% |
| Mar 31, 2024 | 53.11% |
| Dec 31, 2023 | 47.39% |
| Sep 30, 2023 | 43.97% |
| Jun 30, 2023 | 49.17% |
| Mar 31, 2023 | 48.89% |
| Dec 31, 2022 | 41.33% |
| Sep 30, 2022 | 35.95% |
| Jun 30, 2022 | 23.58% |
| Mar 31, 2022 | 92.73% |
| Sep 30, 2021 | 53.25% |
| Jun 30, 2021 | 58.96% |
| Mar 31, 2021 | 93.63% |
| Dec 31, 2020 | 93.81% |
| Sep 30, 2020 | 52.18% |
| Jun 30, 2020 | 45.38% |
| Mar 31, 2020 | 419.42% |
| Dec 31, 2019 | 55.14% |
| Sep 30, 2019 | 52.23% |
| Jun 30, 2019 | 54.49% |
| Mar 31, 2019 | 56.42% |
| Dec 31, 2018 | 58.19% |
| Sep 30, 2018 | 54.63% |
| Jun 30, 2018 | 51.42% |
| Mar 31, 2018 | 53.18% |
| Dec 31, 2017 | -67.66% |
| Sep 30, 2017 | 53.88% |
| Jun 30, 2017 | 95.11% |
| Mar 31, 2017 | 95.62% |
| Dec 31, 2016 | 40.55% |
| Sep 30, 2016 | 94.47% |
| Jun 30, 2016 | 95.57% |
| Mar 31, 2016 | 62.81% |
| Dec 31, 2015 | 190.76% |
| Sep 30, 2015 | 96.62% |
| Jun 30, 2015 | 97.17% |
| Mar 31, 2015 | 62.99% |
| Dec 31, 2014 | 96.96% |
| Sep 30, 2014 | 97.09% |
| Jun 30, 2014 | 63.94% |
| Mar 31, 2014 | 66.16% |
| Dec 31, 2013 | 160.38% |
| Sep 30, 2013 | 71.90% |
| Jun 30, 2013 | 72.11% |
| Mar 31, 2013 | 70.70% |
| Dec 31, 2012 | 72.32% |
| Sep 30, 2012 | 72.48% |
| Jun 30, 2012 | 69.68% |
| Mar 31, 2012 | 67.60% |
| Dec 31, 2011 | 69.16% |
| Sep 30, 2011 | 68.81% |
| Jun 30, 2011 | 71.96% |
| Mar 31, 2011 | 66.51% |
| Dec 31, 2010 | 62.61% |
| Sep 30, 2010 | -489.90% |
| Jun 30, 2010 | 63.85% |